|
End-of-day quote
Dhaka S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 142.10 BDT | -1.52% |
|
-1.73% | +39.18% |
| 10-28 | Beximco Pharmaceuticals plc announces Annual dividend | CI |
| 10-01 | Beximco Pharmaceuticals Reaches Settlement With Bangladeshi Regulator Over Board Restructuring | MT |
Company Valuation: Beximco Pharmaceuticals PLC.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 79,096 | 68,969 | 65,222 | 52,686 | 38,410 | 63,393 | - | - |
| Change | - | -12.8% | -5.43% | -19.22% | -27.1% | 65.04% | - | - |
| Enterprise Value (EV) | 86,052 | 80,148 | 74,677 | 57,836 | 38,410 | 63,393 | 63,393 | 63,393 |
| Change | - | -6.86% | -6.83% | -22.55% | -33.59% | 65.04% | 0% | 0% |
| P/E | 15.4x | 13.5x | 14.1x | 9.04x | 5.53x | 6.97x | 6.39x | 5.48x |
| PBR | 2.14x | 1.7x | 1.49x | 1.1x | 0.8x | 0.98x | 0.88x | 0.78x |
| PEG | - | -155.12x | -1.42x | 0.3x | 0.3x | 0.2x | 0.4x | 0.3x |
| Capitalization / Revenue | 2.68x | 1.99x | 1.66x | 1.19x | 0.78x | 1.16x | 1.03x | 0.92x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.16x | 1.03x | 0.92x |
| EV / EBITDA | 0x | 0x | - | 0x | 0x | 4.94x | 4.47x | 3.96x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 5.88x | 5.25x | 4.59x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 9.43x | 10.5x | 8.88x |
| FCF Yield | 4.42% | 3.33% | 5.31% | 12.1% | 11.6% | 10.6% | 9.51% | 11.3% |
| Dividend per Share 2 | 3.5 | 3.5 | 3.5 | 4 | 4.75 | 6.02 | 6.89 | 8.17 |
| Rate of return | 1.97% | 2.26% | 2.39% | 3.39% | 5.52% | 4.24% | 4.85% | 5.75% |
| EPS 2 | 11.49 | 11.48 | 10.34 | 13.07 | 15.56 | 20.17 | 22.23 | 25.95 |
| Distribution rate | 30.5% | 30.5% | 33.8% | 30.6% | 30.5% | 31% | 31% | 31.5% |
| Net sales 1 | 29,494 | 34,669 | 39,267 | 44,392 | 49,120 | 54,783 | 61,269 | 68,715 |
| EBITDA 1 | 7,765 | 8,543 | - | 10,668 | 11,404 | 12,829 | 14,192 | 16,013 |
| EBIT 1 | 6,651 | 6,901 | 7,216 | 8,674 | 9,848 | 10,772 | 12,064 | 13,812 |
| Net income 1 | 5,141 | 5,123 | 4,612 | 5,830 | 6,941 | 8,662 | 9,919 | 11,578 |
| Net Debt | 6,956 | 11,179 | 9,455 | 5,150 | - | - | - | - |
| Reference price 2 | 177.30 | 154.60 | 146.20 | 118.10 | 86.10 | 142.10 | 142.10 | 142.10 |
| Nbr of stocks (in thousands) | 446,112 | 446,112 | 446,112 | 446,112 | 446,112 | 446,112 | - | - |
| Announcement Date | 11/2/21 | 11/8/22 | 11/1/23 | 11/7/24 | 6/26/26 | 10/29/26 | - | - |
1BDT in Million2BDT
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 7.32x | - | - | 4.24% | 510M | |
| 41.24x | 13.98x | 31x | 0.48% | 1,257B | |
| 39.6x | 6.65x | 18.71x | 1.97% | 651B | |
| 36.2x | 8.44x | 17.42x | 2.4% | 510B | |
| 21.41x | 5.2x | 12.95x | 2.52% | 388B | |
| 98.19x | 6.02x | 25.62x | 2.29% | 366B | |
| 22.92x | 5.89x | 14.21x | 2.72% | 303B | |
| 24.43x | 4.89x | 13.76x | 1.79% | 288B | |
| 29.52x | 7.52x | 13.46x | 2.17% | 252B | |
| -40.78x | 7.43x | 46.67x | 1.94% | 211B | |
| Average | 28.01x | 7.34x | 21.53x | 2.25% | 422.72B | |
| Weighted average by Cap. | 36.23x | 8.78x | 22.70x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BXPHARMA Stock
- Valuation Beximco Pharmaceuticals PLC.
Select your edition
All financial news and data tailored to specific country editions
